Li Honghui, Huang Mao, Wei Zixuan, He Jiawen, Ma Yunong, Lu Cuixia, Jin Albert, Wang Zhixiong, Wen Liewei
Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Jinan University, Zhuhai, China.
Medical College, Guangxi University, Nanning, China.
Front Bioeng Biotechnol. 2022 Oct 7;10:1032571. doi: 10.3389/fbioe.2022.1032571. eCollection 2022.
Photodynamic therapy (PDT) is a promising alternative and palliative therapeutic strategy for colorectal cancer (CRC). A novel photosensitizer with higher selectivity for CRC and fewer side effects is vital for clinical application. Given that the overexpression of hydrogen sulfide (HS) in CRC, it is expected to provide a selective stimulus for activatable photosensitizers that in respond to the specific microenvironment. Herein, we report a novel development of metal-organic frameworks (MOFs) composed of meso-Tetra (4-carboxyphenyl) porphine (TCPP) and ferric ion (Fe) through a facile one-pot process. Experiments both and reveal that the MOF is capable of depredating in response to the high content of HS in tumor microenvironment of CRC. Accompanying with the degradation and release of TCPP, the fluorescence and photosensitivity effect is switched from "off" to "on", enabling the MOF to serve as a HS activatable nano-photosensitizer for real-time fluorescence imaging-guided and targeted PDT of CRC.
Front Bioeng Biotechnol. 2022-10-7
ACS Appl Mater Interfaces. 2022-5-31
Mater Sci Eng C Mater Biol Appl. 2021-12
Mikrochim Acta. 2024-12-26
Front Pharmacol. 2022-5-11
Front Bioeng Biotechnol. 2021-12-2
Photodiagnosis Photodyn Ther. 2021-12